Switch View
© PR Newswire
08.10.2025
ISIN: US0043971052
Accuray Inc
ARAY
LISTED
NASDAQ
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
News Preview
5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Radiation Treatments for More Communities Across Australia.
MADISON, Wis., Oct. 8, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARA...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
News Preview
Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions
Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries
WARSAW, Ind., Oct. 8, 2025 /PRNewswire/ -- Zimmer Biom...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US89532M1018
Trevi Therapeutics Inc
TRVI
LISTED
NASDAQ
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting
News Preview
Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF)
Associate Professor Imran Sati...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
08.10.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the H.C. Wainwright Genetic Medicines Virtual Conference.
Format: Management will participate in a fireside chat and...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
08.10.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Invitation: Sobi's Q3 2025 report
News Preview
STOCKHOLM, Oct. 8, 2025 /PRNewswire/ -- Sobi plans to publish its report for the third quarter of 2025 on 23 October 2025 at 08:00 CEST.
Investors, analysts, and the media are invited to a conference call on the same day at 13:00 CEST, 12:00 BST, and 07:00 EDT. The call will include a presentation...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US46120E6023
Intuitive Surgical Inc
ISRG
LISTED
NASDAQ
Intuitive expands AI and advanced imaging integration in Ion Endoluminal System
News Preview
FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures ...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
News Preview
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
News Preview
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States
GALWAY, Ireland, Oct. 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced the start of the...
Themefolio
Profiler
Peergroup
© Newsfile
08.10.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrantsWhite Bear Lake, Minnesota--(Newsfile Corp. - October 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, toda...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US3773221029
Glaukos Corp
GKOS
LISTED
NYSE
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release third quarter 2025 financial results after the market close on Wednesday, October 29, 2025. The company’s management will discuss the result...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth Announces DOJA as Dedicated Canadian Medical Facility
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced that its DOJA facility in Kelowna, British Columbia is now operating exclusively as a medical cultivation site supporting the Company’s Spectrum The...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
Exact Sciences Schedules Third Quarter 2025 Earnings Call
News Preview
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2025 financial results after the close of the U.S. financial markets on November 3, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. E...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
08.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation
News Preview
FRANKLIN LAKES, N.J., Oct. 8, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboratio...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology
News Preview
Provisional patent application...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US4579852082
Integra Lifesciences Holdings Corp
IART
LISTED
NASDAQ
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
News Preview
Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
ROCKVILLE, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the third quarter 2025 af...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US09073N3008
Streamex Exchange Corp.
STEX
LISTED
NASDAQ
Streamex Corp. (NASDAQ: STEX) to Participate in the 28th Annual Needham Growth Conference
News Preview
LOS ANGELES, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a vertically integrated commodity tokenization company, today announced that members of its executive management team will participate in the 28th Annual Needham Growth Conference, to be held January 13–14, 2026, in New York City....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US92243A2006
Vaxart Inc
VXRT
LISTED
NASDAQ
Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it will present research highlighting its advances in its norovirus and...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US15713L1098
CervoMed Inc.
CRVO
LISTED
NASDAQ
CervoMed Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies
News Preview
Significant improvement relative to placebo on primary outcome measure, change in Clinical Dementia Rating Sum of Boxes (CDR-SB), demonstrated in a within-subject analysis in participants with low likelihood of having Alzheimer’s disease (AD) co-pathology...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US03843E1047
Aquestive Therapeutics Inc
AQST
LISTED
NASDAQ
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™
News Preview
WARREN, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the United States Patent and Trademark Office (USPTO) has...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference
News Preview
Conference presentation...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: AU000000IMC7
Immuron Limited
IMC
LISTED
ASX
Immuron Submits IMM-529 IND to FDA
News Preview
Key Points...
Themefolio
Profiler
Peergroup
© Newsfile
08.10.2025
ISIN: CH1129677105
Medmix AG
MEDX
LISTED
SIX
medmix Wins One of the Largest New Beauty Businesses in Company History and Strengthens Position in Key Global Beauty Markets with Facility Extensions
News Preview
Baar, Switzerland--(Newsfile Corp. - October 8, 2025) - medmix AGNeuhofstrasse 20CH-6430 Baarcommunications@medmix.com www.medmix.swissMEDIA RELEASEDOWNLOAD MEDIA RELEASE medmix Wins One of the Largest New Beauty Businesses in Company History and Strengthens Position in Key Global Beauty Markets with Facility Extensions me...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US98937L1052
Zenas BioPharma, Inc.
ZBIO
LISTED
NASDAQ
Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis
News Preview
- Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now in Phase 3 development for progressive forms of Multiple Sclerosis (MS) - ...
Themefolio
Profiler
Peergroup
© EQS Newswire
08.10.2025
ISIN: CH1251125998
Relief Therapeutics Holding SA
RLF
LISTED
SIX
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
News Preview
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
Companies sign definitive agreement following previously announced binding term sheet
Transaction to create an expanded, SIX-listed, commercial-stage, AI-driven, scalable health tech company
Combined company to be renamed MindMaze Therapeuti......
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US90400D1081
Ultragenyx Pharmaceutical Inc
RARE
LISTED
NASDAQ
Ultragenyx annuncia l'approvazione da parte dell'AIFA (Agenzia Italiana del Farmaco) del rimborso di Evkeeza® (evinacumab) per i pazienti pediatrici di età pari a 6 mesi con ipercolesterolemia familiare omozigote (HoFH)
News Preview
MILANO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), azienda biofarmaceutica focalizzata sullo sviluppo e la commercializzazione di nuove terapie per malattie genetiche rare e ultra-rare, ha annunciato oggi che l'AIFA (Agenzia Italiana del Farmaco) ha esteso il rimborso di Evkeeza® (evinacumab) per il trattamen...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
News Preview
AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
News Preview
AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: KYG1996C1006
CARsgen Therapeutics Holdings Limited
2171
LISTED
HKSE
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology
News Preview
SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of CT071 (an autologous CAR T-cell product targeting GPRC5D) for the treatment of relapsed/refractory multiple myeloma (R/...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US29664W1053
Esperion Therapeutics Inc
ESPR
LISTED
NASDAQ
Esperion Announces Pricing of Public Offering of Common Stock
News Preview
ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C), today announc...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS ANNOUNCES LIFE OFFERING
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Oct. 7, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it is undertaking a non-bro...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS ANNOUNCES LIFE OFFERING
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it is undertaking a...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Encompass Health announces date of 2025 third quarter earnings call
News Preview
BIRMINGHAM, Ala., Oct. 7, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept. 30, 2025, after the market closes on Wednesday, Oct. 29, 2025. The Company will host an investor conference call at 10 a.m. ET on Thursday, Oct. 30, 2025, to d...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Rosen Law Firm Encourages MoonLake Immunotherapeutics Investors to Inquire About Securities Class Action Investigation - MLTX
News Preview
NEW YORK, Oct. 7, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US5926881054
Mettler-Toledo International Inc
MTD
LISTED
NYSE
Mettler-Toledo International Inc. to Host Third Quarter 2025 Earnings Conference Call
News Preview
Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its third quarter 2025 financial results after the market close on Thursday, November 6, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Pres...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 7, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purcha...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US6907321029
Owens & Minor Inc
OMI
LISTED
NYSE
PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR
News Preview
Standalone P&HS anticipated to benefit from Platinum's carve-out experience, sector expertise and commitment to growth
Owens & Minor to retain a 5% equity stake in the business
LOS ANGELES, Oct. 7, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 7, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) bet...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US00404A1097
Acadia Healthcare Company Inc
ACHC
LISTED
NASDAQ
Acadia Healthcare Appoints Todd Young as Chief Financial Officer
News Preview
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced the appointment of Todd Young as Chief Financial Officer, effective October 27, 2025. Tim Sides, who has been serving as the Company’s interim CFO since August 2025, will resume his role as Senior Vice President, Operations Finance.
Young brings to Acadia...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US6907321029
Owens & Minor Inc
OMI
LISTED
NYSE
Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake
News Preview
Owens & Minor, Inc. (NYSE: OMI) today announced that it has entered into a definitive agreement for the sale of the Company’s Products & Healthcare Services (P&HS) segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive hom...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 7, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR).
IF YOU AR...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 7, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH)....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX)....
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: CA00288U1066
Abcellera Biologics Inc
ABCL
LISTED
NASDAQ
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
News Preview
AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:
Truist Securities BioPharma Symposium, November 6, 2025
Stifel Healthcare Conference, November 11-13, 2025
Jefferies Global Healthcare Conference, November 18-20, 2025
Piper Sandler 37th Annual Healthcare Conference, Decemb...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK)....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US64125C1099
Neurocrine Biosciences Inc
NBIX
LISTED
NASDAQ
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial Results
News Preview
Conference Call and Webcast Scheduled for Tuesday, October 28
SAN DIEGO, Oct. 7, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its third quarter 2025 financial results conference call and webcast for 1:30...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Rosen Law Firm Urges Molina Healthcare, Inc. (NYSE: MOH) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”). Molina is a health insurance company.
For more information, sub...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Deadline Alert: Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming December 2, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the “Class...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH CLASS ACTION LAWSUIT: Molina Healthcare, Inc. Medical Costs Trigger Securities Fraud Class Action after Stock Plummets 16% -- Investors Urged to Contact BFA Law
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential violations of the federal securities laws.
If you invested in Molina, you are encouraged to obtain additional information by visiting: https://...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US4525253062
ImmuCell Corporation
ICCC
LISTED
NASDAQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
News Preview
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales r...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on October 1, 2025 to 27 new non-executive employees as equity inducement...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US92511W1080
Verrica Pharmaceuticals Inc
VRCA
LISTED
NASDAQ
Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
News Preview
WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that it will be presenting both an oral presentation and a poster on VP-315, its oncolytic peptide fo...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOLINA HEALTHCARE SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Molina Healthcare, Inc. - MOH
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 2, 2025 to file lead plaintiff applications in a securities class action lawsuit against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH), if they purchased or otherwise acqui...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies to Participate in Fall 2025 Conferences and Events
News Preview
Daytime Emmy Awards participation - 2 nomination for 'Shelter Me: Cancer Pioneers' Comparative Oncology documentary that features clinicians, veterinarians and human & canine patients who participated in OST-HER2 clinical trialsNew York, New York--(Newsfile Corp. - October 7, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "t...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CH0432492467
Alcon AG
ALC
LISTED
NYSE
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
News Preview
CHARLOTTE, N.C., Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement outlining its opposition of the...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
07.10.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced results from a Phase I-II clinical study at Skåne University Hospital in Lund, Sweden evaluat...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
Ipsen - September 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
News Preview
Monthly information relative to the total number of voting rights and shares composing the share capital...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
